Large-scale testing (Phase 3)Study completedNCT01121848What this trial is testingRandomized Study With Oxaliplatin in 2nd Line Pancreatic CancerWho this might be right forPancreatic Neoplasms Sanofi 108
Testing effectiveness (Phase 2)UnknownNCT00178763What this trial is testingHyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas CancerWho this might be right forPancreatic Neoplasms The University of Texas Health Science Center, Houston 36
Testing effectiveness (Phase 2)Looking for participantsNCT06662006What this trial is testingNal-IRI/5-FU/LV Chemotherapy Combined With PD-L1 Inhibitor and Multi-target Anti-angiogenic Small Molecule±SBRT as Second-line Therapy in Metastatic Pancreatic Cancer PatientsWho this might be right forAdvanced Metastatic Pancreatic Cancer The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 56
Testing effectiveness (Phase 2)Temporarily pausedNCT03417921What this trial is testingABTL0812 in Pancreatic CancerWho this might be right forPancreatic Cancer Ability Pharmaceuticals SL 60
Testing effectiveness (Phase 2)Study completedNCT00002955What this trial is testingCombination Chemotherapy in Treating Patients With Advanced Cancer of the PancreasWho this might be right forPancreatic Cancer University of Southern California 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT06710132What this trial is testingStudy of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)Who this might be right forSolid TumorsGastric CancerNon-Small Cell Lung Cancer (NSCLC)+2 more EMD Serono Research & Development Institute, Inc. 184
Early research (Phase 1)Study completedNCT02646748What this trial is testingPembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid TumorsWho this might be right forColorectal Cancer (CRC)Endometrial CancerMelanoma+8 more Incyte Corporation 159
Not applicableAvailableNCT06872489What this trial is testingExpanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid TumorsWho this might be right forNeuroblastoma in ChildrenNeuroblastoma, Recurrent, RefractoryAdvanced Cancer+7 more Second Life Therapeutics
Testing effectiveness (Phase 2)WithdrawnNCT06090318What this trial is testingMilademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A LossWho this might be right forAdvanced Solid TumorCDKN2ANSCLC+7 more Rain Oncology Inc
Early research (Phase 1)Looking for participantsNCT04890613What this trial is testingStudy of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) MutationWho this might be right forAdvanced Solid Tumor Senhwa Biosciences, Inc. 52
Testing effectiveness (Phase 2)Study completedNCT00497224What this trial is testingPhase II Trial of Erlotinib in Advanced Pancreatic CancerWho this might be right forCancerPancreas University Health Network, Toronto 51
Early research (Phase 1)Study completedNCT06378047What this trial is testingIrreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic CancerWho this might be right forPancreatic CancerLocally Advanced Pancreatic Cancer H. Lee Moffitt Cancer Center and Research Institute 2
Testing effectiveness (Phase 2)Study completedNCT00965718What this trial is testingEvaluate the Efficacy and Safety of Activated T-lymphocyte Cell Therapy in Advanced Pancreatic CancerWho this might be right forPancreatic Cancer GC Cell Corporation 20
Large-scale testing (Phase 3)UnknownNCT00541021What this trial is testingGemcitabine With or Without Sorafenib in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerWho this might be right forPancreatic Cancer Institut Paoli-Calmettes 104
Very early researchLooking for participantsNCT04005690What this trial is testingTargeted Pathway Inhibition in Patients With Pancreatic CancerWho this might be right forLocally Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8+5 more OHSU Knight Cancer Institute 90
Testing effectiveness (Phase 2)Study completedNCT05708950What this trial is testingA Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)Who this might be right forCancerSolid TumorMelanoma+14 more Kineta Inc. 40
Early research (Phase 1)Ended earlyNCT03685591What this trial is testingPF-06952229 Treatment in Adult Patients With Advanced Solid TumorsWho this might be right forBreast NeoplasmsProstate NeoplasmsNeoplasms, Squamous Cell+6 more Pfizer 49
Early research (Phase 1)Study completedNCT02159989What this trial is testingSapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryWho this might be right forAdvanced Malignant Solid NeoplasmFibrolamellar CarcinomaMetastatic Malignant Solid Neoplasm+5 more National Cancer Institute (NCI) 83
Early research (Phase 1)Study completedNCT02526017What this trial is testingStudy of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced CancersWho this might be right forAdvanced Solid TumorsHead and Neck CancerPancreatic Cancer+4 more Five Prime Therapeutics, Inc. 313
Not applicableStudy completedNCT02080650What this trial is testingCharacterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)Who this might be right forProstate CancerRenal Cell CarcinomaBladder Cancer+5 more Duke University 62